期刊文献+

利培酮对偏执型精神分裂症患者血糖及血脂代谢的影响 被引量:5

The effect of risperidone on glucose and lipid metabolism in patients with paranoid schizophrenia
原文传递
导出
摘要 目的探讨究利培酮对首发偏执型精神分裂症患者糖脂代谢影响。方法2006年2月~2010年2月间入我院子利培酮治疗的偏执型精神分裂症患者124例,分析利培酮治疗8周前后的血糖、胆固醇、甘油三酯浓度。结果(1)利培酮治疗后,血糖略有下降,但差异无统计学意义(t=1.252,P=0.257),男女之间血糖改变无差异;(2)利培酮治疗后,血胆固醇明显升高(t=4.556,P〈0.01)、血甘油三酯明显升高(t=2.438,P〈0.05),差异均有统计学意义,且男性患者组血胆固醇(t=3.216,P〈0.01)、与甘油三酯(t=2.381,P〈0.05)升高较女性明显。结论利培酮对首发偏执型分裂症患者血脂存在影响,并存在性别差异,而对于空腹血糖的影响不明显。 Objective To explore the effects of risperidone on glucose and lipid metabolism in schizophrenic patients with their first episode. Methods 124 first--episode drug--na? ve schizophrenic patients were recruited, who were admitted to our hospital from January 2006 to January 2010. The plasma concentrations of BS, TC and TG after 8 week risperidone treatment were analysed. Results (1)Eight weeks after risperidone treatment, blood glucose decreased slightly and insignificant statistically. There was no difference in blood glucose level between sexes. (2)After risperidone treatment, TC (t = 4. 556,P 〈 0.01) and TG (t = 2. 438,P 〈0.05) concentrations were significantly increased. Moreover,male patients showed more severe side--effects in their lipid metabolism than females (P 〈0.01 ,P 〈0.05). Conclusions Risperidone had side--effects on the lipid metabolism with gender difference, but no effect on blood glucose.
出处 《神经疾病与精神卫生》 2011年第2期119-121,共3页 Journal of Neuroscience and Mental Health
基金 国家自然科学基金(81000581) 上海市科学自然基金(10ZR1425700)作者单位:(施小平、庄开岑、张其荣) (李则挚、易正辉、张晨)通讯作者:张晨Email:zhang-.chen@msn.tom 方贻儒Email:yirufang@yahoo.corn.cn
关键词 精神分裂症 血糖 血脂 利培酮 首发 Schizophrenia Blood glucose Blood lipid Risperidone First--episode
  • 相关文献

参考文献19

  • 1Saha S,Chant D,Welham J,et al. A systematic review of the prevalence of schizophrenia[J]. Plos Med, 2005,2 (5) : 413 -- 433.
  • 2Edward K, Shaloo G, Susan B, et al. Adherence and outcomes associated with copayment burden in schizophrenia: a cross-- sectional survey[J]. J Med Econ,2010,13(2) : 185-- 192.
  • 3Leucht S, Burkard T, Henderson J,et al. Physical illness and schizophrenia:a review of the literature [J]. Acta Psychiatr- Scand,2007,116(5) :317--333.
  • 4Bellivier F. Schizophrenia antipsychotics and diabetes:Genetic aspects[J]. Eur Psychiatry. 2005,20(S4) :335-- 339.
  • 5Mehta S,Johnson ML,Chen H,et al. Risk of Cerebrovascular Adverse Events in Older Adults Using Antipsychotic Agents: A Propensity--Matched Retrospective Cohort Study[J]. J Clin Psychiat,2010,71 (6) :689--698.
  • 6Ren XS,Herz L,Qian,et al. Measurement of treatment adherence with antipsychotie agents in patients with schizophrenia [J]. Neuropsychiat r Dis Treat, 2009,5 : 491 -- 498.
  • 7Ray WA. Both typical and atypical antipsychotic agents were associated with increased risk for sudden cardiac death[J]. Ann Intern Med,2009,151(4) :JC2--JC12.
  • 8Mclntyre RS, Jerrell JM. Antipsychotic Agents and Cardiometabolic Morbidity in Youth Reply [J]. Arch Pediat Adol Med,2009,163(4):395--395.
  • 9刘俊彪,吴靖华.氯丙嗪、氯氮平、利培酮对首发精神分裂症患者糖代谢、血脂和体重的影响[J].中国神经精神疾病杂志,2004,30(4):293-295. 被引量:41
  • 10郑一瑾,王高华,程自立,臧德馨,王惠玲,吕明春.氯氮平和利培酮对首发精神分裂症患者糖代谢影响的研究[J].中华精神科杂志,2003,36(4):207-210. 被引量:48

二级参考文献32

共引文献165

同被引文献42

  • 1乔颖,闻晖,陈海莹,项志清,薛振康,宋振华,黄继忠.长期住院治疗的精神分裂症患者代谢综合征风险研究[J].上海精神医学,2008,20(2):65-68. 被引量:21
  • 2胡建民,马效芝.利培酮与奋乃静治疗脑血管病所致精神障碍对照研究[J].中国实用医药,2007,2(33):55-56. 被引量:5
  • 3孙静,张志珺,王丛杰,张晓斌,王筱兰,尚晓芳,朱荣鑫.长期服用抗精神病药对脂肪酸与血糖的影响[J].临床精神医学杂志,2004,14(5):259-261. 被引量:12
  • 4冯永平,韩春美,杨晓东,赵玉萍.精神药物治疗期间发生的脑梗塞11例分析[J].山东精神医学,1996,9(2):31-34. 被引量:5
  • 5Heft M D,Schreurs V,Sweers K,et al. Typical and atypical antipsy- chotics differentially affect long- term incidence rates of the metabolic syndrome in first--episode patients with schizophrenia: A retrospective chart review[J]. Sehizophr Res, 2008,101 (1-3) : 295- 303.
  • 6Newcomer J W. Metabolic syndrome and mentalillness [J]. Am J Manag Care,2007,13:170-177.
  • 7Kraus T,Haack M,Sehuld A,et al. Bold weight and lept in plasma levels during treatment with antipsyehotic drugs [J]. Am J Psychia- try, 1999,156(2) : 312-314.
  • 8Casey D E,Zorn S H. The pharmacology of weight gain with anti-- psychotics on glucose and lipid levels [J]. J Clin Psychiatry, 2002, 63:856-865.
  • 9Parsons B, A Uison D B, Loebel A, et al. Weight effects associated with anti- psychotics: A comprehensive database analysis [J]. Sehizophr Res,2009,110(1-3) :103-110.
  • 10Kingsbury S J,Fagek M,Trufasiu D, et al. The apparent ef{ects of ziprasidone on plasma lipids and glucose [J]. J Clin Psychialry, 2001, 62(5) 347-349.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部